The sinus infection has returned—thankfully, not as severe as last time. I’m cautiously optimistic it stays that way, though another round of antibiotics seems inevitable (and unwelcome). On a brighter note, the back pain is finally easing up. One step forward, one flare-up at a time.
I’ve officially stepped back from YouTube. All my videos are now unlisted or private. It’s not a dramatic exit—just a quiet shift. My health hasn’t improved, and I no longer have the energy to sustain both this blog and the channel. The research papers are done, too. That chapter has closed.
There’s one final project I’m still working on. I hope to finish it before I die. It’s not grand, but it matters to me.
I’ll continue blogging here and on my personal site for as long as I’m able. No promises, no schedule—just presence, when I can offer it.
In 2022, 28 U.S. physicians endorsing drugs or devices on X (previously Twitter) made nearly $1.5 million from companies who make these products, a cross-sectional study found.
This article presents a critical analysis of navigating headwinds and seizing opportunities in China’s economic crossroads, based on Yaroslav Lissovolik’s blog.
You may already know that magnesium is one of the top supplements for healthy aging, but its benefits go beyond supporting you in your golden years. “It’s essential for all stages of life,” says Andrea Wong, Ph.D., senior vice president for scientific and regulatory affairs at the Council for Responsible Nutrition (CRN).
You must be logged in to post a comment.